... havevalidated the oncogenic potential of TRIP-Br2. Overex-pression of TRIP-Br2 resulted in the upregulation of E2F-mediated transcription, the transformation of NIH3T3fibroblasts and the promotion of ... interrogated to determine the in silico gene expressionprofiling of TRIP-Br2 across all human tissues. The NCBIsymbol SERTAD2 was used in the query of the GNFSymAtlas database. The median (med) was ... TRIP-Br2-specific siRNAs, DS1 and DS2, at the higher dose of 40 pmol. There were no changes in the transcript levels of other TRIP-Br gene family members upon treatment withTRIP-Br2-specific siRNAs,...